Stock News

AMGEN TO PRESENT AT THE GOLDMAN SACHS 44TH ANNUAL GLOBAL HEALTHCARE CONFERENCE
Is AbbVie or Amgen the Better Bargain Buy Right Now?
Lina Khan Is Upending One of Wall Street’s Favorite Trades
Analysis-Stelara patent deal puts J&J back on path to $57 billion 2025 revenue forecast
AMGEN PRESENTS NEW LUMAKRAS® (SOTORASIB) CODEBREAK 200 CNS DATA AT ASCO 2023
3 Undervalued Biotech Stocks to Buy Before They Blast Off
Dow Jones Today: Debt Vote Drives Index Higher
Why AbbVie and Amgen Are Moving Lower Today
Is Amgen a Good Dividend Stock?
AMGEN PRESENTS NEW SCIENTIFIC AND CLINICAL RESEARCH ACROSS ITS DIVERSE ONCOLOGY PORTFOLIO AND PIPELINE AT ASCO 2023
AMGEN PRESENTS NEW RESEARCH ON OTEZLA® (APREMILAST) IN PSORIATIC ARTHRITIS AT EULAR 2023
AMGEN TO PRESENT AT THE TD COWEN 4TH ANNUAL ONCOLOGY INNOVATION SUMMIT

As seen on...